Uscom Ltd
Uscom Limited is an Australia-based medical technology company specializing in development and marketing of non-invasive cardiovascular and pulmonary medical devices.
The business
Uscom Limited is an Australia-based medical technology company specializing in development and marketing of non-invasive cardiovascular and pulmonary medical devices. The Company offers three suites of devices in the field of cardiac, vascular and pulmonary monitoring: the USCOM 1A advanced haemodynamic monitor, the Uscom BP+ central blood pressure monitor, and the Uscom SpiroSonic digital ultrasonic spirometers. The USCOM 1A is a non-invasive advanced haemodynamic monitor that measures cardiovascular function, detects irregularities and is used to guide treatment. The Uscom BP+ is a supra-systolic oscillometric central blood pressure monitor which measures blood pressure and blood pressure waveforms at the heart, as well as in the arm, information only previously available using invasive cardiac catheterization. The Uscom SpiroSonic digital ultrasonic spirometers are high fidelity, digital, pulmonary function testing devices based on multi-path ultrasound technology.
Small Caps Research
No research on Uscom Ltd yet
We cover the ASX small-cap market one company at a time. Request coverage and we’ll prioritise UCM based on demand.
Share price
Market Statistics
Valuation
Trading Activity
Performance
Latest news
Uscom posts drop in half-yearly results, restructures global distribution model for new release products
Australian medical technology company Uscom (ASX: UCM) has posted a 35% drop in total revenue figures for the half-year ending December 2019, underpinned by a restructure to its China-based distribution model. In January, the company commissioned a new subsidiary office in Beijing with first imports of its 1A cardiovascular monitoring devices into the market occurring […]
Coronavirus creates urgent demand for Uscom 1A monitoring devices in China
The ongoing coronavirus outbreak in China is making itself felt in a commercial sense as medical technology company Uscom (ASX: UCM), a supplier of monitoring devices, announced a material increase in orders for its USCOM 1A device in China during the past five weeks. Confirmed cases of the coronavirus have risen to more than 40,554 […]
Uscom obtains IP protection for medical devices in Chinese market
Australian medical technology company Uscom (ASX: UCM) has been granted four new copyrights and four trademarks by the Chinese government in relation to its 1A, BP+ and SpiroSonic medical devices. The copyrights were issued by the National Copyright Administration, while the trademarks were published by the Trademark Office for the State Administration of Industry & […]
Looking for charts & signals? See the tab.
Unlock the full research library - free.
Create a free account to access every broker report, CEO interview, IPO alert, and daily market wrap. No credit card. No paywall.